全文获取类型
收费全文 | 332277篇 |
免费 | 38647篇 |
国内免费 | 1396篇 |
出版年
2018年 | 3442篇 |
2017年 | 3131篇 |
2016年 | 4413篇 |
2015年 | 6087篇 |
2014年 | 7207篇 |
2013年 | 9872篇 |
2012年 | 11000篇 |
2011年 | 11025篇 |
2010年 | 7454篇 |
2009年 | 6600篇 |
2008年 | 9307篇 |
2007年 | 9649篇 |
2006年 | 9043篇 |
2005年 | 8616篇 |
2004年 | 8642篇 |
2003年 | 8403篇 |
2002年 | 8177篇 |
2001年 | 14508篇 |
2000年 | 14497篇 |
1999年 | 11600篇 |
1998年 | 4026篇 |
1997年 | 4084篇 |
1996年 | 3897篇 |
1995年 | 3901篇 |
1994年 | 3888篇 |
1993年 | 3741篇 |
1992年 | 9876篇 |
1991年 | 9443篇 |
1990年 | 9262篇 |
1989年 | 8981篇 |
1988年 | 8367篇 |
1987年 | 8005篇 |
1986年 | 7242篇 |
1985年 | 7337篇 |
1984年 | 6053篇 |
1983年 | 5305篇 |
1982年 | 4180篇 |
1981年 | 3694篇 |
1980年 | 3513篇 |
1979年 | 6097篇 |
1978年 | 4543篇 |
1977年 | 4269篇 |
1976年 | 3963篇 |
1975年 | 4294篇 |
1974年 | 4651篇 |
1973年 | 4710篇 |
1972年 | 4353篇 |
1971年 | 4066篇 |
1970年 | 3436篇 |
1969年 | 3333篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Michael P. Gustafson Yi Lin Mary L. Maas Virginia P. Van Keulen Patrick B. Johnston Tobias Peikert Dennis A. Gastineau Allan B. Dietz 《PloS one》2015,10(3)
The development of flow cytometric biomarkers in human studies and clinical trials has been slowed by inconsistent sample processing, use of cell surface markers, and reporting of immunophenotypes. Additionally, the function(s) of distinct cell types as biomarkers cannot be accurately defined without the proper identification of homogeneous populations. As such, we developed a method for the identification and analysis of human leukocyte populations by the use of eight 10-color flow cytometric protocols in combination with novel software analyses. This method utilizes un-manipulated biological sample preparation that allows for the direct quantitation of leukocytes and non-overlapping immunophenotypes. We specifically designed myeloid protocols that enable us to define distinct phenotypes that include mature monocytes, granulocytes, circulating dendritic cells, immature myeloid cells, and myeloid derived suppressor cells (MDSCs). We also identified CD123 as an additional distinguishing marker for the phenotypic characterization of immature LIN-CD33+HLA-DR- MDSCs. Our approach permits the comprehensive analysis of all peripheral blood leukocytes and yields data that is highly amenable for standardization across inter-laboratory comparisons for human studies. 相似文献
2.
3.
4.
5.
6.
A. A. Minervina A. Y. Komkov I. Z. Mamedov Y. B. Lebedev 《Doklady. Biochemistry and biophysics》2016,467(1):85-88
T cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignant neoplasm of the lymphocyte precursors that suffered malignant transformation arresting the lymphoid cell differentiation. Clinical studies revealed monoor, more rarely, oligoclonal nature of the disease. A precise identification of malignant clone markers is both the crucial stage of early diagnostics and the essential prognostic factor for therapeutic treatment. Here we present an improved system for unbiased detection of lymphoblastic clones in bone marrow aspirates of T-ALL patients. The system based on multiplex PCR of rearranged T-cell receptor locus (TRB) and straightforward sequencing of the resulted PCR fragments. Testing of the system on genomic DNA from Jurkat cell line and four clinical bone marrow aspirates revealed a set of unique TRB rearrangements that precisely characterize each of tested samples. Therefore, the outcome of the system produces highly informative molecular genetic markers for further monitoring of minimal residual disease in T-ALL patients. 相似文献
7.
A common problem that is encountered in medical applications is the overall homogeneity of survival distributions when two survival curves cross each other. A survey demonstrated that under this condition, which was an obvious violation of the assumption of proportional hazard rates, the log-rank test was still used in 70% of studies. Several statistical methods have been proposed to solve this problem. However, in many applications, it is difficult to specify the types of survival differences and choose an appropriate method prior to analysis. Thus, we conducted an extensive series of Monte Carlo simulations to investigate the power and type I error rate of these procedures under various patterns of crossing survival curves with different censoring rates and distribution parameters. Our objective was to evaluate the strengths and weaknesses of tests in different situations and for various censoring rates and to recommend an appropriate test that will not fail for a wide range of applications. Simulation studies demonstrated that adaptive Neyman’s smooth tests and the two-stage procedure offer higher power and greater stability than other methods when the survival distributions cross at early, middle or late times. Even for proportional hazards, both methods maintain acceptable power compared with the log-rank test. In terms of the type I error rate, Renyi and Cramér—von Mises tests are relatively conservative, whereas the statistics of the Lin-Xu test exhibit apparent inflation as the censoring rate increases. Other tests produce results close to the nominal 0.05 level. In conclusion, adaptive Neyman’s smooth tests and the two-stage procedure are found to be the most stable and feasible approaches for a variety of situations and censoring rates. Therefore, they are applicable to a wider spectrum of alternatives compared with other tests. 相似文献
8.
Four classes of Xanthomonas campestris mutants were identified with respect to pectate lyase. Pectate lyase production in the wild-type and classes I and IIb mutants was partially dependent on the growth-phase whereas in classes IIa and III it was totally dependent. Enzyme activity in some of the mutants was constitutive and resistant to catabolite repression. 相似文献
9.
B. Oderfeld-Nowak W. Jegliski M. Skup J. Skangiel-Kramska M. Zaremba D. Koczyk 《Journal of neurochemistry》1993,61(1):116-119
Abstract: The glial fibrillary acidic protein (GFAP) content was investigated using immunoblotting techniques in the septum and hippocampus of the rat after bilateral lateral fimbria transection. Seven days after surgery GFAP content increased significantly both in the septum (140% of control) and hippocampus (120% in dorsal, the less denervated, and 145% in the most denervated ventral part), indicating the occurrence of reactive gliosis. The GM1 treatment caused statistically significant attenuation of GFAP increment in all hippocampal parts. In contrast, GM1 treatment has no influence on the increase of GFAP content in the septum. Results suggest a differential effect of GM1 on the two gliotic reactions formed as a consequence of the lesion at the level of the source of innervation (septum) and the target (hippocampus). 相似文献
10.